Bluelight therapeutics
WebFiled in April 14 (2024), the BLUELIGHT THERAPEUTICS covers Biochemical reagents used for non-medical purposes; non-medical biochemical reagents and consumables, namely, preparation reagents, labeling reagents, immobilizing reagents, detection reagents and buffers for scientific, research or diagnostic use used for non-medical purposes ... WebMay 27, 2024 · BlueLight Therapeutics is a biotechnology company that uses a novel structure-function-based approach to develop new therapeutic molecules against …
Bluelight therapeutics
Did you know?
Web5AM’s portfolio of advanced life science technologies is diversified within the healthcare industry’s biopharmaceutical, drug delivery technology and research instrument sectors. We support companies that are working to … WebBlueLight Therapeutics, Inc. 7 years 9 months CEO Aug 2024 - Dec 20243 years 5 months South San Francisco Recruited by founders to take over …
WebAt BlueLight Therapeutics, Bill Burkoth has 5 colleagues including Ariel Notcovich (CEO & Director), Monica Beam (Director) … Industry Colleagues In the Biotechnology industry, Bill Burkoth has 28,536 colleagues in 2,155 companies located in 41 countries. 14,528 executive movements have been recorded in the last 12 months. WebMar 18, 2024 · UCB is a global biopharmaceutical company focused on creating value for people living with severe diseases in immunology and neurology now and into the future. …
http://finance.minyanville.com/minyanville/news/read?GUID=39991151 WebSee BlueLight Therapeutics funding rounds, investors, investments, exits and more. Evaluate their financials based on BlueLight Therapeutics's post-money valuation and revenue.
WebMay 27, 2024 · BlueLight Therapeutics raised $15,000,000 / Series A from 5AM Ventures and 2 other investors . Discover more funding rounds . News ...
WebBlueLight Therapeutics. Follow. Join to edit. Follow. Join to edit. BlueLight Therapeutics uses a proprietary structure-based platform to discover small molecules against difficult-to-drug targets. Industries. Biotechnology, Health Care +1. Headquarters. Burlingame, United States. Stage. Series C. Employees. 11-50. smith and wesson model 42WebInflammation & ImmunologyTreatment at the molecular level VaccinesPreventing the spread of infections OncologyThe science of optimism Anti InfectivesCombatting an evolving risk … smith and wesson model 41 valueWebSep 7, 2024 · BlueLight Therapeutics Overview. BlueLight Therapeutics leverages a proprietary, structure-driven platform to develop novel therapeutic molecules against challenging, high-value drug targets. We have a passionate and experienced team with unique expertise on developing structural assays across a broad range of target classes. smith and wesson model 41 wikipediaWebThe ASCPT 2024 Annual Meeting was held as an in-person event with an online component, March 22-24, at the Hyatt Regency in Atlanta, GA. Registrants for the in … ritesh singh ageWebOct 8, 2024 · Founded: 2008. Focus: Regenerative Medicine. What they do: MiMedx is a biopharmaceutical company that develops, manufactures and markets regenerative … ritesh singh curajWebFeaturing Research and Development Instruments, Facility Support and FF&E. smith and wesson model 422 clipWebMay 27, 2024 · Biodesy Inc. today announced that it has changed its corporate name to BlueLight Therapeutics Inc., effective May 20, 2024, and appointed drug discovery expert Mark Gallop, PhD, as Chief Scientific Officer.The new brand identity aligns with the company’s long-term strategic focus on applying its proprietary, structure-driven platform … smith and wesson model 422 holster